Journal
CURRENT OPINION IN VIROLOGY
Volume 17, Issue -, Pages 110-115Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2016.03.002
Keywords
-
Categories
Funding
- NIH/NIAID CEIRS [HHSN272201400004C, HHSN266200700006C, U19AI057266]
Ask authors/readers for more resources
Serum antibodies are the major correlate of influenza vaccine efficacy, providing short-term protection against infection. Recent efforts have been focused on studying antibody responses at a monoclonal level to understand their role in protection against influenza, and to ultimately improve vaccine strategies to provide broader, long-term immunity against influenza virus. These studies have shown that broadly neutralizing antibodies specific for the conserved stem domain of the hemagglutinin protein can target multiple strains of influenza. These antibodies show great promise both from a therapeutic perspective as well as for guiding vaccine design efforts. In this review, we will summarize past and recent findings about broadly neutralizing antibodies against influenza, and discuss how these findings may guide development of universal vaccine strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available